1. Home
  2. OP vs SILO Comparison

OP vs SILO Comparison

Compare OP & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OP
  • SILO
  • Stock Information
  • Founded
  • OP 2021
  • SILO 2010
  • Country
  • OP Greece
  • SILO United States
  • Employees
  • OP N/A
  • SILO N/A
  • Industry
  • OP
  • SILO Apparel
  • Sector
  • OP
  • SILO Consumer Discretionary
  • Exchange
  • OP Nasdaq
  • SILO Nasdaq
  • Market Cap
  • OP 8.5M
  • SILO 8.8M
  • IPO Year
  • OP N/A
  • SILO N/A
  • Fundamental
  • Price
  • OP $1.13
  • SILO $1.54
  • Analyst Decision
  • OP
  • SILO
  • Analyst Count
  • OP 0
  • SILO 0
  • Target Price
  • OP N/A
  • SILO N/A
  • AVG Volume (30 Days)
  • OP 11.1K
  • SILO 600.9K
  • Earning Date
  • OP 12-20-2024
  • SILO 02-18-2025
  • Dividend Yield
  • OP N/A
  • SILO N/A
  • EPS Growth
  • OP N/A
  • SILO N/A
  • EPS
  • OP N/A
  • SILO N/A
  • Revenue
  • OP $25,729,000.00
  • SILO $72,102.00
  • Revenue This Year
  • OP N/A
  • SILO $1.86
  • Revenue Next Year
  • OP N/A
  • SILO N/A
  • P/E Ratio
  • OP N/A
  • SILO N/A
  • Revenue Growth
  • OP 36.33
  • SILO N/A
  • 52 Week Low
  • OP $1.02
  • SILO $0.77
  • 52 Week High
  • OP $3.15
  • SILO $4.50
  • Technical
  • Relative Strength Index (RSI)
  • OP 40.22
  • SILO 52.57
  • Support Level
  • OP $1.11
  • SILO $1.56
  • Resistance Level
  • OP $1.24
  • SILO $1.89
  • Average True Range (ATR)
  • OP 0.05
  • SILO 0.19
  • MACD
  • OP -0.00
  • SILO -0.05
  • Stochastic Oscillator
  • OP 7.17
  • SILO 27.12

About OP OceanPal Inc.

OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: